BIOWKS — Bio-Works Technologies AB Balance Sheet
0.000.00%
- SEK310.39m
- SEK275.46m
- SEK62.50m
Annual balance sheet for Bio-Works Technologies AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 103 | 65.9 | 39.4 | 34.3 | 34.9 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 6.25 | 11 | 8.33 | 4.07 | 15.7 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 119 | 89.2 | 59.7 | 50.7 | 69 |
| Net Property, Plant And Equipment | 1.78 | 2.43 | 2.49 | 1.82 | 1.71 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 121 | 91.6 | 62.2 | 52.5 | 70.8 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 12.4 | 23.9 | 18.1 | 7.91 | 21.5 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 12.4 | 23.9 | 18.1 | 7.91 | 21.6 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 109 | 67.7 | 44 | 44.6 | 49.2 |
| Total Liabilities & Shareholders' Equity | 121 | 91.6 | 62.2 | 52.5 | 70.8 |
| Total Common Shares Outstanding |